A Phase 2 Study of Palliative Radiation Therapy and Anti-PD-1/PD-L1 Checkpoint Blockade in Patients With Metastatic Merkel Cell Carcinoma
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Merkel cell carcinoma
- Focus Therapeutic Use
Most Recent Events
- 05 Aug 2021 Status changed from active, no longer recruiting to discontinued.
- 22 Mar 2021 Status changed from recruiting to active, no longer recruiting.
- 01 Aug 2019 Status changed from not yet recruiting to recruiting.